PPD, a Wimington-based drug-research firm, reported stronger third-quarter results late Tuesday.
The company's revenue rose to $365.4 million, up 7 percent from the same period last year. Operating income of $56.8 million was a 10 percent improvement.
PPD, which celebrated its 25th anniversary this summer, has a large Triangle operation with about 1,400 local employees. The company conducts clinical trials for pharmaceutical companies developing experimental drugs, and provides other services.
It's one of the largest players in the contract research organization industry, which is concentrated in the Triangle.
PPD shares closed Tuesday at $25.72, up 38 cents.
PPD executives, including CEO David Grange, will discuss the latest results at 9 a.m. Listen to that discussion here.